What does CUSIP 87159A103 represent in this 13F holders report?

CUSIP 87159A103 is the security identifier for GEVA - SYNAGEVA BIOPHARMA CORP - COM used to aggregate holder disclosures.

How many institutions held GEVA - SYNAGEVA BIOPHARMA CORP - COM in Q2 2013?

1 institutional investor reported GEVA - SYNAGEVA BIOPHARMA CORP - COM for Q2 2013. Use the holders table for investor-level position and value details.

SYNAGEVA BIOPHARMA CORP - COM (GEVA)

CUSIP: 87159A103

Q2 2013 13F Holders as of 30 Jun 2013

Type / Class: Equity / COM
Total 13F shares: 209,742
Share change: 0
Total reported value: $8,804,000
Price per share: $41.98
Number of holders: 1

Quarterly Holders Quick Answers

What is CUSIP 87159A103?
CUSIP 87159A103 identifies GEVA - SYNAGEVA BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2013

Recent filing periods for CUSIP 87159A103:

Q2 2015 Q1 2015 Q4 2014 Q3 2014 Q2 2014 Q1 2014 Q4 2013 Q3 2013

Institutional Holders of SYNAGEVA BIOPHARMA CORP - COM (GEVA) as of Q2 2013

As of 30 Jun 2013, SYNAGEVA BIOPHARMA CORP - COM (GEVA) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 209,742 shares. The largest 1 holders included WELLS FARGO & COMPANY/MN. This page lists 1 institutional shareholders reporting positions in this security for the Q2 2013 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.